9-35088825-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032634.4(PIGO):​c.*267C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.014 in 370,864 control chromosomes in the GnomAD database, including 263 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 220 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 43 hom. )

Consequence

PIGO
NM_032634.4 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.15

Publications

2 publications found
Variant links:
Genes affected
PIGO (HGNC:23215): (phosphatidylinositol glycan anchor biosynthesis class O) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid which contains three mannose molecules in its core backbone. The GPI-anchor is found on many blood cells and serves to anchor proteins to the cell surface. This protein is involved in the transfer of ethanolaminephosphate (EtNP) to the third mannose in GPI. At least three alternatively spliced transcripts encoding two distinct isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
PIGO Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hyperphosphatasia with intellectual disability syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hyperphosphatasia-intellectual disability syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 9-35088825-G-C is Benign according to our data. Variant chr9-35088825-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 366749.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0975 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGONM_032634.4 linkc.*267C>G 3_prime_UTR_variant Exon 11 of 11 ENST00000378617.4 NP_116023.2 Q8TEQ8-1
PIGONM_001201484.2 linkc.*267C>G 3_prime_UTR_variant Exon 13 of 13 NP_001188413.1 Q8TEQ8-2
PIGONM_152850.4 linkc.*267C>G 3_prime_UTR_variant Exon 12 of 12 NP_690577.2 Q8TEQ8-2
PIGOXM_005251619.4 linkc.*267C>G 3_prime_UTR_variant Exon 11 of 11 XP_005251676.1 Q8TEQ8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGOENST00000378617.4 linkc.*267C>G 3_prime_UTR_variant Exon 11 of 11 1 NM_032634.4 ENSP00000367880.3 Q8TEQ8-1

Frequencies

GnomAD3 genomes
AF:
0.0287
AC:
4362
AN:
152142
Hom.:
221
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.100
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.0158
GnomAD4 exome
AF:
0.00384
AC:
840
AN:
218604
Hom.:
43
Cov.:
4
AF XY:
0.00326
AC XY:
376
AN XY:
115302
show subpopulations
African (AFR)
AF:
0.0972
AC:
685
AN:
7048
American (AMR)
AF:
0.00532
AC:
49
AN:
9208
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
6564
East Asian (EAS)
AF:
0.00
AC:
0
AN:
12736
South Asian (SAS)
AF:
0.000302
AC:
8
AN:
26452
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10414
Middle Eastern (MID)
AF:
0.00321
AC:
3
AN:
936
European-Non Finnish (NFE)
AF:
0.000105
AC:
14
AN:
132866
Other (OTH)
AF:
0.00654
AC:
81
AN:
12380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
39
79
118
158
197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0287
AC:
4368
AN:
152260
Hom.:
220
Cov.:
32
AF XY:
0.0272
AC XY:
2026
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.100
AC:
4156
AN:
41536
American (AMR)
AF:
0.0105
AC:
161
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68014
Other (OTH)
AF:
0.0156
AC:
33
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
187
375
562
750
937
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0211
Hom.:
18
Bravo
AF:
0.0325
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hyperphosphatasia with intellectual disability syndrome 2 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.9
DANN
Benign
0.48
PhyloP100
2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79276933; hg19: chr9-35088822; API